Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Non-Current Debt: 2018

Historic Non-Current Debt for EyePoint Pharmaceuticals (EYPT) over the last 1 years, with Jun 2018 value amounting to $17.3 million.

  • EyePoint Pharmaceuticals' Non-Current Debt rose 148.65% to $32.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $32.0 million, marking a year-over-year increase of 148.65%. This contributed to the annual value of $17.3 million for FY2018, which is N/A change from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Non-Current Debt of $17.3 million as of FY2018.
  • EyePoint Pharmaceuticals' 5-year Non-Current Debt high stood at $17.3 million for FY2018, and its period low was $17.3 million during FY2018.
  • Over the past 1 years, EyePoint Pharmaceuticals' median Non-Current Debt value was $17.3 million (recorded in 2018), while the average stood at $17.3 million.